XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When Henry VIII was diagnosed, it became firmly entrenched in popular belief ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

But in the case of Zurampic (lesinurad) and Duzallo (lesinurad + allopurinol), sales have been ... in its entirety after market testing the drug and assessing results last month.

Now, phase 3 results with a new drug from Sobi and Selecta suggests ... current drugs like allopurinol and febuxostat aren’t able to achieve that objective, and there are estimated to be around ...

They’ll check your uric acid levels to diagnose your condition. Sometimes, they may prescribe a drug such as allopurinol (Zyloprim) or febuxostat (Uloric) to lower your uric acid levels.

allopurinol (a medicine used to treat gout ... and then go back to taking your tablets as you would normally. Do not take a double dose to make up for the dose you missed. If you are not sure ...

Amoxicillin is available in combination with clavulanic acid (Augmentin), which may help with the issue of drug resistance ... Zyloprim (allopurinol) Amoxicillin is an antibiotic that can be ...

Also, it is known to be associated with malnutrition, infections (HIV, Human T-lymphotropic virus), hypothyroidism, celiac disease, autoimmune conditions, sarcoidosis, graft-versus-host disease, and ...